Grafa News and Videos — Page 50

• Neutrl halted redemptions for its US$486 million NUSD stablecoin after reserve concerns emerged around its exposure to Resolv.
• The situation has drawn attention to reserve transparency, collateral structures, and liquidity risks across decentralised stablecoin projects.
• Reserve quality and redemption access remain the key factors separating more resilient stablecoin models from structurally weaker ones.

Tvardi Therapeutics (NASDAQ:TVRD) reported a Q2 2026 net loss of $6.5 million as R&D spending declined to $4 million.

PowerCompute (NASDAQ:PWCM) reported second-quarter revenue of $2.12 million, up 9.8% year over year, as Bitcoin production increased to 27.9 BTC.

Neumora Therapeutics (NASDAQ:NMRA) reported a Q2 2026 net loss of $43.1 million, narrowing from $52.7 million a year earlier.

Outlook Therapeutics (NASDAQ:OTLK) reported a fiscal Q3 net loss of $20.3 million as it prepares to launch FDA-approved wet AMD treatment LYTENAVA.

Teamshares (NASDAQ:TMS) reported second-quarter revenue of $148.7 million, up 20%, while net income improved to $9.5 million from a $12.9 million loss.

Super League (NASDAQ:SLE) reported Q2 gross revenue of approximately $3 million, while net revenue rose 16% sequentially to $1.24 million.

Edible Garden (NASDAQ:EDBL) reported second-quarter revenue of $3.6 million, up 12.8%, while total sales increased 31.2% year over year.

Beneficient (NASDAQ:BENF) reported fiscal Q1 2027 GAAP revenue of $12.2 million and an operating loss of $0.4 million as expenses declined sharply.

MySize (NASDAQ:MYSZ) reported second-quarter revenue of $3.07 million, up 53% year over year, while net loss widened to $1.75 million.